Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Nat Commun ; 12(1): 1653, 2021 03 12.
Article in English | MEDLINE | ID: covidwho-1132073

ABSTRACT

SARS-CoV-2 emerged in late 2019 and caused a pandemic, whereas the closely related SARS-CoV was contained rapidly in 2003. Here, an experimental set-up is used to study transmission of SARS-CoV and SARS-CoV-2 through the air between ferrets over more than a meter distance. Both viruses cause a robust productive respiratory tract infection resulting in transmission of SARS-CoV-2 to two of four indirect recipient ferrets and SARS-CoV to all four. A control pandemic A/H1N1 influenza virus also transmits efficiently. Serological assays confirm all virus transmission events. Although the experiments do not discriminate between transmission via small aerosols, large droplets and fomites, these results demonstrate that SARS-CoV and SARS-CoV-2 can remain infectious while traveling through the air. Efficient virus transmission between ferrets is in agreement with frequent SARS-CoV-2 outbreaks in mink farms. Although the evidence for virus transmission via the air between humans under natural conditions is absent or weak for SARS-CoV and SARS-CoV-2, ferrets may represent a sensitive model to study interventions aimed at preventing virus transmission.


Subject(s)
Air Microbiology , COVID-19/transmission , Ferrets/virology , SARS-CoV-2 , Severe Acute Respiratory Syndrome/transmission , Severe acute respiratory syndrome-related coronavirus , Aerosols , Amino Acid Substitution , Animal Fur/virology , Animals , COVID-19/virology , Disease Models, Animal , Female , Fomites/virology , Influenza A Virus, H1N1 Subtype , Models, Biological , Orthomyxoviridae Infections/transmission , Polymorphism, Single Nucleotide , SARS-CoV-2/genetics , Severe Acute Respiratory Syndrome/virology , Time Factors , Viral Load , Viral Zoonoses/transmission , Viral Zoonoses/virology , Virus Shedding
3.
Nat Med ; 26(9): 1405-1410, 2020 09.
Article in English | MEDLINE | ID: covidwho-653871

ABSTRACT

In late December 2019, a cluster of cases of pneumonia of unknown etiology were reported linked to a market in Wuhan, China1. The causative agent was identified as the species Severe acute respiratory syndrome-related coronavirus and was named SARS-CoV-2 (ref. 2). By 16 April the virus had spread to 185 different countries, infected over 2,000,000 people and resulted in over 130,000 deaths3. In the Netherlands, the first case of SARS-CoV-2 was notified on 27 February. The outbreak started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, and later also outside, the south of the Netherlands. The combination of near to real-time whole-genome sequence analysis and epidemiology resulted in reliable assessments of the extent of SARS-CoV-2 transmission in the community, facilitating early decision-making to control local transmission of SARS-CoV-2 in the Netherlands. We demonstrate how these data were generated and analyzed, and how SARS-CoV-2 whole-genome sequencing, in combination with epidemiological data, was used to inform public health decision-making in the Netherlands.


Subject(s)
Betacoronavirus/genetics , Coronavirus Infections/genetics , Genome, Viral/genetics , Pandemics , Pneumonia, Viral/genetics , Betacoronavirus/pathogenicity , COVID-19 , Clinical Decision-Making , Coronavirus Infections/epidemiology , Coronavirus Infections/pathology , Coronavirus Infections/virology , Humans , Netherlands/epidemiology , Pneumonia, Viral/epidemiology , Pneumonia, Viral/pathology , Pneumonia, Viral/virology , Public Health , SARS-CoV-2 , Whole Genome Sequencing
4.
Lancet Infect Dis ; 20(11): 1273-1280, 2020 11.
Article in English | MEDLINE | ID: covidwho-623256

ABSTRACT

BACKGROUND: 10 days after the first reported case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the Netherlands (on Feb 27, 2020), 55 (4%) of 1497 health-care workers in nine hospitals located in the south of the Netherlands had tested positive for SARS-CoV-2 RNA. We aimed to gain insight in possible sources of infection in health-care workers. METHODS: We did a cross-sectional study at three of the nine hospitals located in the south of the Netherlands. We screened health-care workers at the participating hospitals for SARS-CoV-2 infection, based on clinical symptoms (fever or mild respiratory symptoms) in the 10 days before screening. We obtained epidemiological data through structured interviews with health-care workers and combined this information with data from whole-genome sequencing of SARS-CoV-2 in clinical samples taken from health-care workers and patients. We did an in-depth analysis of sources and modes of transmission of SARS-CoV-2 in health-care workers and patients. FINDINGS: Between March 2 and March 12, 2020, 1796 (15%) of 12 022 health-care workers were screened, of whom 96 (5%) tested positive for SARS-CoV-2. We obtained complete and near-complete genome sequences from 50 health-care workers and ten patients. Most sequences were grouped in three clusters, with two clusters showing local circulation within the region. The noted patterns were consistent with multiple introductions into the hospitals through community-acquired infections and local amplification in the community. INTERPRETATION: Although direct transmission in the hospitals cannot be ruled out, our data do not support widespread nosocomial transmission as the source of infection in patients or health-care workers. FUNDING: EU Horizon 2020 (RECoVer, VEO, and the European Joint Programme One Health METASTAVA), and the National Institute of Allergy and Infectious Diseases, National Institutes of Health.


Subject(s)
Betacoronavirus/genetics , Community-Acquired Infections/epidemiology , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Cross Infection/epidemiology , Health Personnel , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Adult , Aged , COVID-19 , Community-Acquired Infections/virology , Coronavirus Infections/virology , Cross Infection/virology , Cross-Sectional Studies , Female , Genetic Variation , Hospitals, Teaching , Humans , Male , Mass Screening/methods , Middle Aged , Netherlands/epidemiology , Pandemics , Pneumonia, Viral/virology , SARS-CoV-2 , Whole Genome Sequencing , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL